StonvexLoading…
StonvexStonvexStonvexCore line items from TRMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-02 | Annual 2025 2025-01-03 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $3.59B | $3.68B | $3.80B | $3.68B |
Operating Income | $592.00M | $460.70M | $448.80M | $510.90M |
Net Income | $424.00M | $1.50B | $311.30M | $449.70M |
EPS (Diluted) | $1.76 | $6.09 | $1.25 | $1.80 |
Total Assets | $9.31B | $9.49B | $9.54B | $7.27B |
Total Liabilities | $3.48B | $3.74B | $5.04B | $3.22B |
Cash & Equivalents | $253.40M | $738.80M | $229.80M | $271.00M |
Free Cash Flow OCF − CapEx | $360.90M | $497.80M | $555.10M | $348.00M |
Shares Outstanding | 236.00M | 245.80M | 246.50M | 246.90M |